Quote | ABIOMED Inc. (NASDAQ:ABMD)
|Last Trade Date Time:||12/31/1969 07:00:00 pm|
News | ABIOMED Inc. (NASDAQ:ABMD)
Summary Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. They increased NVIDIA, Shopify, NIO Inc., SEA Ltd., Roblox, DoorDash, and Ginkgo Bioworks while reducing Illumina, Ferrari N.V., Arthur J. Gallagher & Co., Albemarle, Meta Platform...
Summary Intuitive Surgical, Inc. is no doubt a nearly perfect company, although the investment is currently worrisome. With continued headwinds and a lofty valuation, a lot rides on what Intuitive Surgical will do with their $4 billion in cash. This article will summarize recent Int...
Message Board Posts | ABIOMED Inc. (NASDAQ:ABMD)
|whytestocks: $ABMD News Article - This medical devices stock opened 50% up on Tuesday: here's why||whytestocks||investorshangout||11/01/2022 2:45:51 PM|
|whytestocks: $ABMD News Article - Uber Rides Higher, but Here's Tuesday's Big Stock Winner||whytestocks||investorshangout||11/01/2022 2:15:52 PM|
|whytestocks: $ABMD News Article - ABMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sa||whytestocks||investorshangout||11/01/2022 2:05:53 PM|
|whytestocks: $ABMD News Article - Abiomed Second Quarter Fiscal 2023 Earnings and Conference Call No||whytestocks||investorshangout||10/13/2022 5:50:57 PM|
|whytestocks: $ABMD News Article - Multi-Center, Multi-Society Study of Impella-supported Patients wi||whytestocks||investorshangout||09/20/2022 7:55:50 PM|
News, Short Squeeze, Breakout and More Instantly...
ABIOMED Inc. Company Name:
ABMD Stock Symbol:
ABIOMED Inc. Website:
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...